Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

Applikon Biotechnology acquires biotech portfolio from HaloteC Instruments

Applikon Biotechnology BV a global leader in bioreactor systems, announced it has signed a definitive agreement to acquire the biotechnology portfolio of HaloteC Instruments BV, a Dutch provider of instruments and software solutions for the biotech market.

This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.

Applikon Biotechnology is committed to continuing to deliver products and software innovations that bring significant efficiencies to our customers while simplifying operations in the biotech laboratories,” said Arthur Oudshoorn, CEO of Applikon Biotechnology. “We believe that the acquisition of the biotech portfolio of HaloteC Instruments will accelerate our development of bioreactor software solutions, allowing our customers to greatly improve the efficiency and performance of their R&D departments. The instrumentation for the food and biofuel industry that HaloteC has developed extends the products offering Applikon Biotechnology for these industries. Organizations are looking for software solutions to allow parallel processing of bioreactor systems and to process the large amount of data generated by these processes. The advanced software solutions  that HaloteC Instruments has developed for these types of applications allow the researcher  to compare large data sets and easily see relations between various parameters. The software and instrumentation excel in ease of operation and robust design and will contribute to the increasing market share of Applikon Biotechnology.”

As part of its strategy to deliver an advanced  datacenter for biotech processes, Applikon Biotechnology continues to invest and innovate to extend the benefits of instrumentation and software solutions for the bioprocess industry.

“Applikon Biotechnology and HaloteC Instruments share a highly aligned vision to remove complexity and increase efficiencies in the biotechnology based R&D laboratories,” said Emo van Halsema, CEO, HaloteC.  “We are excited to combine forces with Applikon to provide customers a more cost-effective, efficient, and easy to operate solution for process development and optimization.”

Terms of the acquisition were not disclosed.

Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report